
National HealthCare Corporation: updates and filings
Price
$190.26
November 20, 2026Market cap $3.0B
What Ploutos Investor adds for National HealthCare
Part of Ploutos Investor, €9.99 a month
- The full history: 10 fiscal years, from 2016
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 6, 2026next Feb 5, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 6, 2026Results of operationsForm8-K
- Nov 6, 2026Other material eventsForm8-K
- Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Oct 30, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 11, 2026Other material eventsForm8-K
- Aug 11, 2026Results of operationsForm8-K
- Aug 6, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 27, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jul 1, 2026Material agreement entered, material agreement ended, acquisition or disposal of assets, new material financial obligation, Regulation FD disclosureForm8-K
- May 27, 2026Material agreement entered, material agreement ended, new material financial obligationForm8-K
- May 15, 2026Material agreement enteredForm8-K
- May 13, 2026Shareholder voteForm8-K
- May 8, 2026Results of operationsForm8-K
- May 7, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 7, 2026Other material eventsForm8-K
- Apr 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 22, 2026Material agreement entered, material agreement ended, Regulation FD disclosureForm8-K
- Apr 2, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 2, 2026Annual meeting proxy statementFormDEF 14A
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 12, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 27, 2026Results of operationsForm8-K
- Feb 26, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Feb 17, 2026Officer or director change, Regulation FD disclosureForm8-K
- Feb 13, 2026Other material eventsForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 6, 2026 | 8-K | Results of operations | Document |
| Nov 6, 2026 | 8-K | Other material events | Document |
| Nov 5, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Oct 30, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 11, 2026 | 8-K | Other material events | Document |
| Aug 11, 2026 | 8-K | Results of operations | Document |
| Aug 6, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 27, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jul 1, 2026 | 8-K | Material agreement entered, material agreement ended, acquisition or disposal of assets, new material financial obligation, Regulation FD disclosure | Document |
| May 27, 2026 | 8-K | Material agreement entered, material agreement ended, new material financial obligation | Document |
| May 15, 2026 | 8-K | Material agreement entered | Document |
| May 13, 2026 | 8-K | Shareholder vote | Document |
| May 8, 2026 | 8-K | Results of operations | Document |
| May 7, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 7, 2026 | 8-K | Other material events | Document |
| Apr 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 22, 2026 | 8-K | Material agreement entered, material agreement ended, Regulation FD disclosure | Document |
| Apr 2, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 2, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 12, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 27, 2026 | 8-K | Results of operations | Document |
| Feb 26, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Feb 17, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Feb 13, 2026 | 8-K | Other material events | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Oct 3, 1997.
The full analysis
What do National HealthCare's filings show?
The filings are where every one of National HealthCare's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.